Prevymis (letermovir) - Merck (MSD)
Antiviral prophylaxis against herpesviruses (herpes simplex virus, varicella-zoster virus and cytomegalovirus) among patients with cancer. (PubMed, Curr Opin Infect Dis) - May 3, 2026 - "As the cancer treatment landscape evolves, ongoing research into optimal antiviral prophylaxis approaches is necessary to improve patient outcomes." 
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Hematological Malignancies • Herpes Simplex • Herpes Zoster • Infectious Disease • Multiple Myeloma • Oncology • Solid Tumor • Transplantation • Varicella Zoster
http://www.ncbi.nlm.nih.gov/pubmed/42068587
 
Alice J Liu; Benjamin W Teh; Michelle K Yong; Violet Z Zhu
 
May 3, 2026
 
Prev Next